Toosendanin-induced change of dopamine level detected by microdialysis in vivo at rat striatum  

作　　者：Wenyan Chen Pingbo Yin Weiling Ye Yuliang Shi 

机构地区：[1]Chinese Acad Sci, Shanghai Inst Physiol, Key Lab Neurobiol, Shanghai 200031, Peoples R China

出　　处：《Chinese Science Bulletin》1999年第12期1106-1110,共5页

摘　　要：To investigate the effect on central nervous transmission of toosendanin (TSN), a presynaptic blocker, rat striatum was perfused in vivo with a TSN-containing artificial cere-brospinal fluid (ACSF) and the level of dopamine (DA) as well as related metabolites in the collected dialysates has been determined by a microbore HPLC with electrochemical detection (mi-crobore HPLC-ECD). The results are as follows: ( i ) TSN induced a biphasic change of DA from its basal level;( ii ) the basal contents of two metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) increased in turn and stayed at a higher level than basal control for a long period. The basal level of 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of 5-hydroxytryptamine(5-HT), had a change similar to that of HVA; (iii) after per-fusion with TSN-containing ACSF, high K+-evoked DA release was inhibited. These results show that TSN does not selectively affect acetylcholine (ACh) release, but probably acts on a commonTo investigate the effect on central nervous transmission of toosendanin (TSN), a presynaptic blocker, rat striatum was perfusedin vivo with a TSN-containing artificial cerebrospinal fluid (ACSF) and the level of dopamine (DA) as well as related metabolites in the collected dialysates has been determined by a microbore HPLC with electrochemical detection (microbore HPLC-ECD). The results are as follows: ( i ) TSN induced a biphasic change of DA from its basal level;( ii ) the basal contents of two metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) increased in turn and stayed at a higher level than basal control for a long period. The basal level of 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of 5-hydroxytryptamine(5-HT), had a change similar to that of HVA; ( iii ) after perfusion with TSN-containing ACSF, high K+-evoked DA release was inhibited. These results show that TSN does not selectively affect acetylcholine (ACh) release, but probably acts on a common mechanism responsible for transmitter release at different synapses by interfering with the proteins involved in fusian and resulting in diffusion of the vesicular contents into the cytoplasm and blockade of normal exocytosis.

关 键 词：PRESYNAPTIC BLOCKER TOOSENDANIN DOPAMINE INTRACEREBRAL MICRODIALYSIS neurotransmitter release. 

分 类 号：R338[医药卫生—人体生理学]